Natural Grocers by Vitamin Cottage, Inc. Income Taxes Disclosure
16. Income Taxes
The following are the components of the provision for income taxes for the years ended September 30, 2025, 2024 and 2023, respectively, dollars in thousands:
|
Year ended September 30, |
||||||||||||
|
2025 |
2024 |
2023 |
||||||||||
|
Current federal income tax expense |
$ | 12,575 | 10,413 | 5,291 | ||||||||
|
Current state income tax expense |
2,516 | 2,408 | 1,311 | |||||||||
|
Total current income tax expense |
15,091 | 12,821 | 6,602 | |||||||||
|
Deferred federal income tax benefit |
(2,246 |
) |
(3,283 | ) | (1,334 | ) | ||||||
|
Deferred state income tax benefit |
(362 |
) |
(672 | ) | (141 | ) | ||||||
|
Total deferred income tax benefit |
(2,608 |
) |
(3,955 | ) | (1,475 | ) | ||||||
|
Total provision for income taxes |
$ | 12,483 | 8,866 | 5,127 | ||||||||
The differences between the United States federal statutory income tax rate and the Company’s effective tax rate are as follows:
|
Year ended September 30, |
||||||||||||
|
2025 |
2024 |
2023 |
||||||||||
|
Statutory tax rate |
21.0 |
% |
21.0 | 21.0 | ||||||||
|
State income taxes, net of federal income tax expense |
2.9 | 2.9 | 3.1 | |||||||||
|
Enhanced food deduction |
(1.3 |
) |
(1.9 |
) |
(3.1 |
) |
||||||
|
Deferred tax liability adjustment |
0.3 | 0.8 | — | |||||||||
|
Other, net |
(1.7 |
) |
(2.1 |
) |
(2.9 |
) |
||||||
|
Effective tax rate |
21.2 |
% |
20.7 | 18.1 | ||||||||
Deferred taxes have been classified on the consolidated balance sheets as follows, dollars in thousands:
|
As of September 30, |
||||||||
|
2025 |
2024 |
|||||||
|
Long-term assets |
$ | — | — | |||||
|
Long-term liabilities |
(7,863 |
) |
(10,471 |
) |
||||
|
Net deferred tax liabilities |
$ | (7,863 |
) |
(10,471 |
) |
|||
The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows, dollars in thousands:
|
As of September 30, |
||||||||
|
2025 |
2024 |
|||||||
|
Deferred tax assets: |
||||||||
|
Trademarks |
$ | 563 | 562 | |||||
|
Finance lease liabilities |
12,132 | 11,511 | ||||||
|
Operating lease liabilities |
68,881 | 73,037 | ||||||
|
Research and experimental expenditures |
855 | 955 | ||||||
|
Accrued paid time off |
802 | 768 | ||||||
|
Equity compensation (1) |
983 | 509 | ||||||
|
Other (1) |
791 | 435 | ||||||
|
Gross deferred tax assets |
85,007 | 87,777 | ||||||
|
Deferred tax liabilities: |
||||||||
|
Property and equipment |
(15,790 |
) |
(17,796 |
) |
||||
|
Finance lease assets |
(10,461 |
) |
(9,944 |
) |
||||
|
Operating lease assets |
(63,442 |
) |
(67,426 |
) |
||||
|
Leasehold improvements |
(1,906 |
) |
(1,919 |
) |
||||
|
Prepaid expenses (1) |
(503 |
) |
(635 |
) |
||||
|
Goodwill (1) |
(737 |
) |
(523 |
) |
||||
|
Other (1) |
(31 | ) | (5 | ) | ||||
|
Gross deferred tax liabilities |
(92,870 | ) | (98,248 | ) | ||||
|
Net deferred tax liabilities |
$ | (7,863 | ) | (10,471 | ) | |||
(1) Equity compensation, prepaid expenses and goodwill at September 30, 2024 have been reclassified from other to be consistent with the current period presentation.
The Company believes that it is more likely than not that it will fully realize all deferred tax assets in the form of future deductions based on the nature of the deductible temporary differences and expected future taxable income.
The Company did utilize any federal income tax loss or tax credit carryforwards for the years ended September 30, 2025, 2024 and 2023. The Company did utilize any tax effected state income tax loss carryforwards for the years ended September 30, 2025, 2024 and 2023.
The Company did have any uncertain tax positions as of September 30, 2025 and 2024.
The Company files income tax returns with federal, state and local tax authorities. With limited exceptions, the Company is no longer subject to federal income tax examinations for fiscal years and prior and is no longer subject to state and local income tax examinations for fiscal years and prior.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Dec 11, 2025 | Showing above |
| 2024 | Dec 12, 2024 | |
| 2023 | Dec 7, 2023 | |
| 2022 | Dec 8, 2022 | |
| 2021 | Dec 9, 2021 | |
| 2020 | Dec 10, 2020 | |
| 2019 | Dec 5, 2019 | |
| 2018 | Dec 6, 2018 | |
| 2017 | Dec 7, 2017 | |
| 2016 | Dec 8, 2016 | |
| 2015 | Dec 10, 2015 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.